PedAM

Pediatric Disease Annotations & Medicines

Disease	breast cancer
Phenotype	C0080032\|malignant pleural effusion
Sentences	9
PubMedID- 26539407	A 59-year-old woman was found to have recurrent hormone receptor positive and her2 positive breast cancer with malignant pleural effusion and bony metastases.
PubMedID- 24909174	Cxcl12-gamma was expressed in metastatic tissues in mice, and we also detected cxcl12-gamma in malignant pleural effusions from patients with breast cancer.
PubMedID- 23992330	The kpl-4 cell line, isolated from the malignant pleural effusion of a breast cancer patient with an inflammatory skin metastasis and resistant to trastuzumab in female athymic nude mice [26], represents another model of intrinsic resistance to trastuzumab, due to p95her2 fragment overexpression.
PubMedID- 24887236	The kpl4 cell line was isolated from the malignant pleural effusion of a breast cancer patient with an inflammatory skin metastasis; these cells are resistant to trastuzumab in female athymic nude mice [22].
PubMedID- 23405099	The cell line was established in j. kurebayashi's lab from the malignant pleural effusion of a breast cancer patient with an inflammatory skin metastasis [20].
PubMedID- 22964933	Clinical and pathological factors influencing the survival of breast cancer patients with malignant pleural effusion.
PubMedID- 21565923	This study retrospectively compared long-term outcomes between two groups of breast cancer patients with malignant pleural effusion (mpe): those receiving only systemic therapy (st) and those receiving st following initial pleurodesis (p-st).
PubMedID- 20051960	The kpl-4 cell line was isolated from the malignant pleural effusion of a breast cancer patient with an inflammatory skin metastasis; in female athymic nude mice, kpl-4 cells are mostly resistant to trastuzumab (kurebayashi et al, 1999).
PubMedID- 23826463	malignant pleural effusion in breast cancer 12 years after mastectomy that was successfully treated with endocrine therapy.

Page: 1